Making the case for dairy proteins in a plant-protein era.
In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”
These days, you can’t be in the supplement biz without being in the transparency biz. Or the traceability one.
The proposed legislation, introduced by State Representative Kay Khan earlier this year, is an updated version of a bill first introduced in 2015.
Traceability, testing, and capacity should be key considerations when vetting an ingredient supplier’s non-GMO supply chain capabilities.
I spoke to CRN’s president and CEO, Steve Mister, about the registry’s progress over the past year.
At Capsugel’s Quality Summit, Experts Focus on the Way Forward for Dietary Supplement Quality Control
Quality assurance, compliance, risk management, and best practices were on the minds of 80 quality professionals who convened at the Capsugel Quality Summit in late August.
The Triple-T program takes a three-pronged approach to supply-chain traceability: trace, test, and trust.
CRN Asks International Trade Commission to Reject Amarin’s Omega-3 Complaint, Citing Legal Deficiencies, Harm to Public Interest
In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.
DolCas Biotech Receives FDA “No Objection” Letter following GRAS Review for BCM-95 Curcumin Ingredient
The company also secured self-affirmed GRAS status for its ingredient back in 2016.